ArticleBioscience reports2020

20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.

Yihang Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.